Nothing to fear? Nurses and doctors react to AHPRA allowing RNs to prescribe S4 and S8 drugs

The AMA harbours some concerns, but says the RN prescribing model is much safer than autonomous pharmacist prescribing.

Prescribing RNs entered Australian healthcare last week, at least conceptually.

AHPRA unveiled a registration standard for RNs to gain an “endorsement for scheduled medicines”, which will allow them to prescribe S4 and S8 drugs under conditions agreed upon with a supervising prescriber — a doctor or nurse practitioner.

Prescribing RNs must have three years of clinical experience under their belts, complete a postgraduate qualification, and undertake a six-month mentorship program with a prescriber.

The training rules mean that the first real-life prescribing nurses will only emerge in 2026, especially as the postgraduate courses will require approval from the Australian Nursing and Midwifery Accreditation Council, which has yet to approve anything.